|
|||
|
|
|
|
 |
Columbia is one of a few institutions in the United States that maintains Arteriosclerosis Specialized Center of Research (SCOR) programs supported by Center grants from the National Heart, Lung, and Blood Institute (NHLBI). The Columbia SCOR comprises a multidisciplinary program of laboratory and clinical research dealing with aspects of the pathophysiology, pathogenesis, diagnosis, treatment, and prevention of atherosclerosis, hyperlipidemia, and atherosclerotic cardiovascular disease. The SCOR has two major integrating research themes: the study of the metabolism of plasma lipoproteins and apolipoproteins in relation to atherosclerosis; and the investigation of atherogenesis and the cell biology of the arterial wall. The SCOR includes several core resource facilities that are available to all participants in its program. These include the core lipid research clinic; core lipid and lipoprotein laboratory; core biomathematics and biostatistics resource facility; core tissue culture laboratory; and molecular biology core laboratory. These core laboratories and resources are available for specialized training of students participating in programs of the Institute of Human Nutrition. |
 |
|